X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2172) 2172
Publication (73) 73
Newsletter (11) 11
Book Review (9) 9
Magazine Article (3) 3
Book Chapter (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2032) 2032
procarbazine - administration & dosage (1775) 1775
vincristine - administration & dosage (1511) 1511
male (1421) 1421
antineoplastic combined chemotherapy protocols - therapeutic use (1346) 1346
female (1343) 1343
prednisone - administration & dosage (1191) 1191
adult (1172) 1172
middle aged (1049) 1049
hodgkin disease - drug therapy (987) 987
doxorubicin - administration & dosage (808) 808
mechlorethamine - administration & dosage (758) 758
cyclophosphamide - administration & dosage (737) 737
adolescent (704) 704
aged (699) 699
oncology (666) 666
bleomycin - administration & dosage (659) 659
combined modality therapy (596) 596
vinblastine - administration & dosage (521) 521
chemotherapy (484) 484
hodgkin disease - radiotherapy (475) 475
dacarbazine - administration & dosage (454) 454
antineoplastic combined chemotherapy protocols - adverse effects (438) 438
antineoplastic combined chemotherapy protocols - administration & dosage (405) 405
hodgkin disease - pathology (377) 377
prognosis (361) 361
child (354) 354
neoplasm staging (346) 346
treatment outcome (345) 345
lomustine - administration & dosage (339) 339
etoposide - administration & dosage (311) 311
procarbazine - adverse effects (309) 309
hodgkin disease - mortality (297) 297
drug therapy, combination (294) 294
procarbazine - therapeutic use (278) 278
follow-up studies (277) 277
radiotherapy (268) 268
remission induction (265) 265
index medicus (253) 253
methotrexate - administration & dosage (252) 252
brain neoplasms - drug therapy (251) 251
vincristine - adverse effects (250) 250
procarbazine (249) 249
antineoplastic agents - administration & dosage (238) 238
hematology (229) 229
hodgkin disease - therapy (229) 229
disease-free survival (223) 223
time factors (214) 214
survival rate (209) 209
prednisone - adverse effects (208) 208
drug administration schedule (206) 206
retrospective studies (204) 204
child, preschool (202) 202
survival analysis (196) 196
vincristine - therapeutic use (188) 188
prednisolone - administration & dosage (182) 182
hodgkin's disease (173) 173
cancer (168) 168
vinblastine (168) 168
therapy (167) 167
clinical trials as topic (163) 163
lymphoma, non-hodgkin - drug therapy (160) 160
prednisone - therapeutic use (156) 156
doxorubicin - adverse effects (154) 154
recurrence (146) 146
mechlorethamine - adverse effects (142) 142
bleomycin - adverse effects (140) 140
animals (138) 138
radiotherapy dosage (138) 138
combination chemotherapy (133) 133
prospective studies (132) 132
cyclophosphamide - adverse effects (124) 124
survival (124) 124
antineoplastic agents - therapeutic use (122) 122
lymphoma - drug therapy (122) 122
clinical neurology (119) 119
disease (118) 118
glioma - drug therapy (116) 116
vincristine (114) 114
cyclophosphamide - therapeutic use (108) 108
aged, 80 and over (104) 104
vinblastine - adverse effects (103) 103
antineoplastic combined chemotherapy protocols (100) 100
brain neoplasms - radiotherapy (100) 100
carmustine - administration & dosage (100) 100
lung neoplasms - drug therapy (100) 100
radiation-therapy (96) 96
dose-response relationship, drug (95) 95
risk factors (95) 95
dacarbazine - adverse effects (94) 94
mechlorethamine - therapeutic use (94) 94
remission, spontaneous (93) 93
hodgkin disease - complications (92) 92
antineoplastic agents - adverse effects (91) 91
brain neoplasms - pathology (90) 90
children (83) 83
mopp (82) 82
astrocytoma - drug therapy (81) 81
temozolomide (81) 81
chemotherapy, adjuvant (80) 80
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1778) 1778
Japanese (87) 87
Russian (77) 77
Polish (60) 60
German (53) 53
French (49) 49
Spanish (35) 35
Italian (15) 15
Chinese (11) 11
Hungarian (8) 8
Dutch (3) 3
Hebrew (3) 3
Portuguese (3) 3
Romanian (2) 2
Serbian (2) 2
Finnish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 04/2016, Volume 34, Issue 11, pp. 1175 - 1181
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2016, Volume 34, Issue 17, pp. 2020 - 2027
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 12, pp. 1188 - 1194
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2017, Volume 35, Issue 16, pp. 1786 - 1794
Journal Article
British Journal of Haematology, ISSN 0007-1048, 05/2014, Volume 165, Issue 4, pp. 534 - 544
The purpose of this national retrospective study was to evaluate the outcome in children with relapsed or primary refractory Hodgkin lymphoma [ HL ] after a... 
refractory disease | relapse | children | odgkin lymphoma | survival | Relapse | Children | Refractory disease | Survival | Hodgkin lymphoma | COMBINED-MODALITY THERAPY | PROGNOSTIC-FACTORS | RADIATION | CHEMOTHERAPY | TRIAL | FRENCH SOCIETY | DISEASE | SALVAGE THERAPY | RADIOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Procarbazine - administration & dosage | Prednisolone - adverse effects | Recurrence | Cyclophosphamide - administration & dosage | Prednisolone - administration & dosage | Follow-Up Studies | Humans | Vinblastine - administration & dosage | Cyclophosphamide - adverse effects | Hodgkin Disease - surgery | Hodgkin Disease - mortality | Vincristine - administration & dosage | Child | Dacarbazine - administration & dosage | Dexamethasone - administration & dosage | Hematopoietic Stem Cell Transplantation | Etoposide - administration & dosage | Combined Modality Therapy | Bleomycin - administration & dosage | Remission Induction | Cytarabine - administration & dosage | Ifosfamide - administration & dosage | Adolescent | Vincristine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epirubicin - administration & dosage | Cisplatin - administration & dosage | Hodgkin Disease - radiotherapy | Multicenter Studies as Topic | Hodgkin Disease - drug therapy | Retrospective Studies | Radiotherapy, Adjuvant | Doxorubicin - administration & dosage | Chlorambucil - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Ifosfamide - adverse effects | Kaplan-Meier Estimate | Treatment Outcome | Clinical Trials as Topic | Disease-Free Survival | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Carmustine - administration & dosage | Patient outcomes | Diseases
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2010, Volume 28, Issue 27, pp. 4199 - 4206
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2013, Volume 31, Issue 2, pp. 231 - 239
Purpose To optimize fertility advice in patients with Hodgkin lymphoma (HL) before therapy and during survivorship, information on the impact of chemotherapy... 
INHIBIN-B | PRESERVATION | OUTCOME MEASURE | OVARIAN RESERVE | ONCOLOGY | TERM FOLLOW-UP | DISEASE | FEMALE CANCER SURVIVORS | ANTI-MULLERIAN HORMONE | CHEMOTHERAPY | SERUM MARKER | Procarbazine - administration & dosage | Cyclophosphamide - administration & dosage | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - administration & dosage | Cyclophosphamide - adverse effects | Gonadotropin-Releasing Hormone - analogs & derivatives | Fertility - physiology | Fertility Preservation | Young Adult | Vinblastine - adverse effects | Follicle Stimulating Hormone - blood | Hodgkin Disease - drug therapy | Oligospermia - epidemiology | Vincristine - administration & dosage | Adult | Female | Gonadotropin-Releasing Hormone - therapeutic use | Hodgkin Disease - physiopathology | Inhibins - blood | Menstrual Cycle - drug effects | Testosterone - blood | Menstrual Cycle - physiology | Doxorubicin - administration & dosage | Dacarbazine - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Prednisone - adverse effects | Survivors | Etoposide - administration & dosage | Ovary - physiology | Hodgkin Disease - epidemiology | Bleomycin - administration & dosage | Bleomycin - adverse effects | Germany - epidemiology | Randomized Controlled Trials as Topic | Pregnancy | Testis - physiology | Hodgkin Disease - blood | Procarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - adverse effects | Doxorubicin - adverse effects | Index Medicus
Journal Article
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, ISSN 1520-4391, 2009, Volume 2009, Issue 1, pp. 497 - 506
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2005, Volume 23, Issue 36, pp. 9198 - 9207
Journal Article
Journal Article
The Lancet Oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1680 - 1687
A high proportion of patients with relapsed classical Hodgkin's lymphoma achieve a response with the antibody-drug conjugate brentuximab vedotin, and the drug... 
ABVD | COPP | ONCOLOGY | DISEASE | BEACOPP | REGIMEN | OPEN-LABEL | HD15 TRIALS | CHEMOTHERAPY | STANDARD | Procarbazine - administration & dosage | Predictive Value of Tests | Confidence Intervals | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Prospective Studies | Hodgkin Disease - pathology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Immunoconjugates - administration & dosage | Dose-Response Relationship, Drug | Neoplasm Invasiveness - pathology | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Vincristine - administration & dosage | Adult | Female | Doxorubicin - administration & dosage | Immunoconjugates - adverse effects | Prednisone - administration & dosage | Etoposide - adverse effects | Prednisone - adverse effects | Drug Administration Schedule | Risk Assessment | Kaplan-Meier Estimate | Etoposide - administration & dosage | Treatment Outcome | Bleomycin - administration & dosage | Bleomycin - adverse effects | Disease-Free Survival | Procarbazine - adverse effects | Survival Analysis | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Germany | Clinical trials | Care and treatment | Product development | Lymphomas | Biological products | Analysis
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 05/2017, Volume 2017, Issue 5, pp. CD007941 - CD007941
Journal Article